Please enable Javascript
Hematology & Blood Cancer
Advertisement
Myelofibrosis Patient Advocacy Group Panel Provides Insights on Patient Experiences, Needs
Cecilia Brown
MPN
|
October 3, 2024
The panel used an iterative process to create patient-facing and provider-facing consensus statements across 7 domains.
Read More
Nurse Practitioner Shares Why Blood Cancer Awareness Month Is Critical
Amy Pierre, RN, BSN, ANP-BC
Hematology & Blood Cancer
|
September 27, 2024
Blood Cancer Awareness Month represents a critical opportunity to provide education on early signs and symptoms.
View More
A Rewarding Career: APP Reflects on Profession During Advanced Practice Provider Week
Lisa Hwa, APRN, CNP, DNP, MS
Professional Development
|
September 26, 2024
Lisa Hwa, APRN, CNP, DNP, MS, speaks about her work as an APP and the importance of National APP Week.
View More
National APP Week: Nurse Practitioner Discusses the Critical Role of APPs in Oncology
Amy Pierre, RN, BSN, ANP-BC
Professional Development
|
September 26, 2024
Amy Pierre, RN, BSN, ANP-BC, shares what the annual observance means to her and the field as a whole.
View More
TKIs and Renal Function: Researchers Evaluate Outcomes in Africa
Bereket Abraha Molla, MD
Conferences
|
September 20, 2024
Researchers evaluated the renal status of more than 250 patients receiving TKIs in a chronic myeloid leukemia clinic.
View More
Study Evaluates BTKi Treatment Patterns, Disparities in US Community Setting
Scott D. Goldfarb, PharmD, MS
Conferences
|
September 19, 2024
Researchers presented the results of the observational study at the 2024 SOHO Meeting.
View More
How COVID-19 Affects Patients With AML
Mamtha Balla, MD, MPH, FACP, FAPCR
Conferences
|
September 18, 2024
Research presented at the Annual Meeting of the Society of Hematologic Oncology provided insights on outcomes and risks.
View More
Nurse Practitioner Reflects on Evolution of Blood Cancer Treatment
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO
Hematology & Blood Cancer
|
September 18, 2024
Hear about an NP's journey into hematologic oncology and how she has seen the treatment landscape evolve.
View More
Ruxolitinib Shows Durable Hematocrit Control, Improved Symptom Control in PV
Cecilia Brown
Conferences
|
September 13, 2024
An analysis of the RESPONSE and RESPONSE-2 studies further supports the benefit of ruxolitinib in these patients.
Read More
How Nurses Can Raise Awareness of Common Blood Cancer Symptoms
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO
Hematology & Blood Cancer
|
September 13, 2024
Learn how nurses can educate their peers, their patients, and the public about blood cancers and their symptoms.
View More
Demographics May Illuminate Needs of Patients in Remission From Multiple Myeloma
Cancer Nursing Today Editors
Hematology & Blood Cancer
|
October 2, 2024
A study of more than 10,000 patients illuminated the characteristics and needs of patients who are in remission.
Read More
Program Improves Outcomes, Satisfaction With Nursing Care in Patients With Myeloma
Cancer Nursing Today Editors
Multiple Myeloma
|
September 6, 2024
Learn how an innovative rehabilitation model improved clinical outcomes and patient satisfaction with nursing care.
Read More
Addressing Unmet Needs in Multiple Myeloma: Insights From Patient, Caregiver Experiences
Cancer Nursing Today Editors
Multiple Myeloma
|
September 5, 2024
Learn about the diverse unmet needs and potential solutions related to the experiences of patients and caregivers.
Read More
How Depression Is Related to Outcomes in Patients With Lymphoid, Hematopoietic Malignancies
Cancer Nursing Today Editors
Conferences
|
September 4, 2024
New research shows that major depressive disorder is associated with certain outcomes in this population of patients.
Read More
What Oncology Practice Managers Say About the Impacts of CML Treatment Intolerance
Cecilia Brown
Conferences
|
September 4, 2024
Nurses, nurse administrators, physician assistants, and oncologists/hematologists shared their insights with researchers.
Read More
3 Tips for Oncology Nurses Caring for Patients With Blood Cancers
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO
Hematology & Blood Cancer
|
September 4, 2024
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO, shares 3 key tips for nurses caring for these patients.
View More
Ciltacabtagene Autoleucel 'May Overcome the Poor Prognosis' Associated With Functionally High-Risk Multiple Myeloma
Cecilia Brown
Hematology & Blood Cancer
|
September 4, 2024
A subgroup analysis of CARTITUDE-4 evaluated ciltacabtagene autoleucel in functionally high-risk multiple myeloma.
Read More
Digital Preventive Interventions Are Needed for Adult Survivors of Childhood ALL
Robert Dillard
Hematology & Blood Cancer
|
September 4, 2024
Digital interventions that target physical and mental well-being are needed for adult long-term survivals of ALL.
Read More
Survey: Nearly All Patients With Multiple Myeloma Want to be Involved in Treatment Decisions
Cecilia Brown
Hematology & Blood Cancer
|
September 3, 2024
The survey results will be used to formulate recommendations to improve patient involvement in decision making.
Read More
Study Highlights Need for Interventions to Improve Prognostic Understanding in Patients With Blood Cancer
Cecilia Brown
Hematology & Blood Cancer
|
September 2, 2024
Nurses may be able to play a role in aligning views between patients and hematologists on prognosis and goals of care.
Read More
Load More
Advertisement
Advertisement
Advertisement